Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12121527 Anthracycline-based antibody drug conjugates having high in vivo tolerability

Overview Structured Data Issues Contributors Activity

All edits

Edits on 23 Oct, 2024

"Created via: Patent importer"

Golden AI

created this topic on 23 Oct, 2024

Edits made to:

Infobox (+45 properties)

Article (+135 characters)

‌

US Patent 12121527 Anthracycline-based antibody drug conjugates having high in vivo tolerability

Article

Patent abstract

The present invention relates to antibody drug conjugates (ADCs) presenting improved properties of in vivo tolerability.

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121215270

Patent Inventor Names

Remy Gebleux0

Roger Beerli0

Ulf Grawunder0

Date of Patent

October 22, 2024

Patent Application Number

169258020

Date Filed

July 10, 2020

Patent Citations

‌

US Patent 7462608 Non nucleoside reverse transcriptase inhibitors

‌

US Patent 8212009 Methods and compounds for lymphoma cell detection and isolation

‌

US Patent 8703801 Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications

‌

US Patent 9150647 Biological inhibitors of ROR1 capable of inducing cell death

‌

US Patent 9163258 Method for the treatment of obesity

‌

US Patent 9228023 Anti-ROR1 antibodies and methods of use for treatment of cancer

‌

US Patent 9242014 Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

‌

US Patent 9266952 Antibodies against ROR1 and uses thereof

‌

US Patent 9316646 Anti-human ROR1 antibodies

‌

US Patent 9758586 Chimeric rabbit/human ROR1 antibodies

‌

US Patent 9872923 Method of producing an immunoligand/payload conjugate

‌

US Patent 9933434 Therapeutic antibodies against ROR-1 protein and methods for use of same

‌

US Patent 9938350 Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

‌

US Patent 10041090 Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby

‌

US Patent 10188745 Binding protein drug conjugates comprising anthracycline derivatives

‌

US Patent 10517959 Binding protein drug conjugates comprising anthracycline derivatives

‌

US Patent 10618959 ROR1 antibody compositions and related methods

‌

US Patent 10758556 Anthracycline-based antibody drug conjugates having high in vivo tolerability

‌

US Patent 10864277 Method of producing an immunoligand/payload conjugate

‌

US Patent 10960083 Binding protein drug conjugates comprising anthracycline derivatives

‌

US Patent 11364301 Method of producing an immunoligand/payload conjugate

Patent Primary Examiner

CPC Code

Find more entities like US Patent 12121527 Anthracycline-based antibody drug conjugates having high in vivo tolerability

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API